RT Journal Article
SR Electronic
T1 COVID-19 IN INDIA: MODELLING, FORECASTING AND STATE-WISE COMPARISON
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.15.20131375
DO 10.1101/2020.06.15.20131375
A1 Jose, Ankitha
A1 Salim, Ashid
A1 Subhash, Silpa
A1 George, Noel
YR 2020
UL http://medrxiv.org/content/early/2020/06/16/2020.06.15.20131375.abstract
AB COVID-19 has turned the whole world upside down economically and socially. COVID-19 pandemic has caused around five crores of cases and three lakhs deaths globally as of 27 May 2020. This paper adopts four mathematical growth models. Basic models are encouraged because these models can make predictions with the available data and variables in the current scenario of COVID-19 pandemic. The best-fitted model is identified in accordance with the value of the coefficient of determination. As per the best model, there might be greater than 16 lakhs cases at the infection end in India. After predicting the future size of the pandemic, we analyzed how the disease severity varies among the Indian states and union territories using Case Fatality Rates (CFR).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors declare that they have no known competing financial interests or personal relationships which might seem to have influenced the work reported in this paper.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:St.Thomas College, PalaiAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yeshttps://www.kaggle.com/sudalairajkumar/covid19-in-india?select=covid_19_india.csv https://ourworldindata.org/coronavirus https://www.kaggle.com/sudalairajkumar/covid19-in-india?select=covid_19_india.csv https://ourworldindata.org/coronavirus